Elon Musk has said that the first person to receive the Blindsight version of Neuralink will be treated this year.

Neuralink received US FDA approval for the Blindsight chip in September 2024. It was designated as a 'breakthrough device'.

Elon Musk's brain-chip company Neuralink is set to implant its revolutionary Blindsight chip on its first human patient in ...

Blindsight received ‘breakthrough’ status from the US Food and Drug Administration (FDA) in September last year. It has been ...

Neuralink’s Blindsight implant aims to restore vision for the blind using a brain-computer interface, with future potential for superhuman sight beyond human capabilities.

Elon Musk's startup, Neuralink, plans to implant its artificial visual prosthesis, 'Blindsight', in a human for the first time by late 2025.

The US Food and Drug Administration (FDA) has awarded a "Breakthrough Device" status to Neuralink’s experimental vision-restoring implant, Blindsight. This designation is intended to fast-track ...

Blindsight, the artificial intelligence (AI)-driven vision safety solution, has been named joint winner of the Queensland ...

Elon Musk said his brain chip startup Neuralink aims to have its artificial visual prosthesis, Blindsight, implanted in a ...